Indazole compounds as kinase inhibitors
US12071428B2 · kind B2 · utility
0Cited by
53References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 22, 2024 |
| Grant date | Aug 27, 2024 |
| Priority date | — |
| Expiry date | Feb 22, 2044 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D495/10
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Disclosed herein are compounds and methods of treating diseases and/or conditions associated with FGFR inhibition.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.